Sept. 30-Oct. 1, 2019 Omaha

register at: mwdrugdevelopment.com

Cincinnati Children’s HospitalKansas State UniversityMayo Clinic Purdue UniversityUniversity of ColoradoUniversity of IowaUniversity of Kansas

University of KentuckyUniversity of MissouriUniversity of Missouri-KCUniversity of NebraskaUniversity of Notre DameUniversity of OklahomaWARF

in one place!

Fourteen major Midwest medical research institutions with

their best and brightest technologies

Sept. 30-Oct. 1, 2019 Omaha

TWO DAY CONFERENCE Featuring about 50 of the best early- and mid-stage

therapeutic technologies that Midwestern insititutions have to offer.

A glance at some of the planned presentations for 2019: Antibacterials for methicillin, vancomycin resistant bacteria Antibiotics to treat highly resistant enterococcus Antimicrobial peptides for therapeutics Antisense oligonucleotides to treat spinal muscular atrophy Autologous CD117+ progenitor cell therapy for allograft prolongation

Combine nanoparticles, checkpoint blockade therapy Composite biodegradable formulation promotes bone regeneration in

diabetics Enhance vaccine responses Family of small molecule drugs to treat diabetes complications Fast-acting, reversible neuromuscular blockers

GGDPS inhibitors for the treatment of cancer Glucocorticoid prodrugs for the treatment of nephritis GM-CSF to treat Alzheimer’s disease GRP94-selective therapeutics to treat cancer, glaucoma Kappa opioid receptor antagonists to treat depression, anxiety

Liposomal formulations of combinational antibiotics Low-molecular weight anti-PD-L1 peptide for cancer immunotherapy Matrix metalloproteinase inhibitors to treat diabetic foot ulcers

Updated: April 5, 2019

CINCINNATI CHILDREN’S

SUPPLIER HANDBOOK

B R A N D G U I D E U P D A T E D 2 0 1 7

1

Mayo Clinic and Arizona State University Alliance for Health Care Brand Standards

IntroductionThis brand style guide provides standards and guidelines to represent the relationship and activities in the Mayo Clinic and Arizona State University Alliance for Health Care, which is a formal agreement between the two organizations focused on improving patient care, accelerating innovative research discoveries and transforming medical education. The guide is based on the need for consistent and accu-rate branding of the relationship. Adherence to the style guide will help ensure respect for the value and integrity of both the Mayo Clinic and Arizona State University brands, promote a successful collaboration and expedite reviews and approvals.

The guide will be updated regularly based on the ongoing relationship and the business needs of the Mayo Clinic and Arizona State University Alliance for Health Care. Scenarios not covered in this guide will be added as new use-cases emerge. The Mayo Clinic Department of Public Affairs (including Office of Brand Management) and ASU Knowledge Enterprise Development Strategic Partnerships oversee development of this guide. The entire document will be examined annually. Approval of the style guide occurs through the Mayo and ASU Steering Committee.

This first version of the guide was approved on December 13, 2017.

Contents

About the Brands . . . . . . . . . . . . . . . . . . . . . 2

About the Alliance. . . . . . . . . . . . . . . . . . . . . 2

Activities in the Alliance . . . . . . . . . . . . . . . . . . 3

Guiding Principles. . . . . . . . . . . . . . . . . . . . . 6

Naming Conventions . . . . . . . . . . . . . . . . . . . 6

Review and Approval . . . . . . . . . . . . . . . . . . . 7

Graphic Representation/Graphic Element . . . . . . . . . 8

Approved Artwork . . . . . . . . . . . . . . . . . . . . 9

Examples . . . . . . . . . . . . . . . . . . . . . . . . . 11

Name and Graphic Element in Headlines . . . . . . . . . 13

Preferred Colors . . . . . . . . . . . . . . . . . . . . . 14

Trademark Notifications . . . . . . . . . . . . . . . . . . 16

Inappropriate Use of Graphic Element and/or Name . . . 16

Key Messages . . . . . . . . . . . . . . . . . . . . . . 17

Media-specific Guidelines . . . . . . . . . . . . . . . . . 18

Startups

www.mwdrugdevelopment.com

Nanoparticle drug delivery systems Novel Compounds to treat AML, MDS Novel crocetin compound prevents, treats pancreatic cancer

Novel licofelone analogs for chronic inflammatory diseases, epithelial cancers

Novel mithramycin derivatives for cancer chemotherapy Novel peptide antagonists for modulating GPCR pharmacology Peptide-based methods to treat neurological injury, disease Preventative therapy treats post-traumatic osteoarthritis

Protease inhibitor drugs with improved PK, bioavailability Small molecule inhibitors of NAMPT Small molecule ligand for PSMA-targeted radioligand therapy Small molecule Rac inhibitor as new therapy Small molecule therapeutic for lupus

Small molecule treatment targets lymphoblastic leukemia/lymphoma Treat macular degeneration with cell therapy Treat multiple myeloma and other solid cancers VSV cDNA libraries for cancer immuno/virotherapy

U N I V E R S I T Y O F K E N T U C K Y G R A P H I C S TA N D A R D S

GRAPHICSTANDARDS

updated May 2016

17

MIZZOU IDENTITY

UNIVERSITY OF MISSOURI SIGNATURE

The university’s signature is a combination of the stacked MU logo and the official school

wordmark, which is the name “University of Missouri.”

The signature is part of a coordinated visual identity that includes consistent use of the MU

logo, colors and typefaces. It must be used in print and electronic communications as well as

promotional materials, such as banners and stickers.

The proportional relationship between the stacked MU logo and the wordmark may not be

altered. The stacked MU logo must always appear to the left or centered above the wordmark.

It may not appear to the right or centered below the wordmark.

The wordmark is composed in the typeface Janson Text. The spacing between the letters and

between words has been adjusted for maximum effect and should not be altered.

Do not attempt to re-create any part of the signature, including the wordmark. Rather

contact the Joint Office of Strategic Communications & Marketing at identity@missouri.edu

to request original artwork files.

Primary Signature (Horizontal)

Primary Signature (Vertical)

2017-18A Guide to WARF Support for UW–Madison

WARF exists to benefit UW–Madison

$12 million Faculty Recruitment and Retention

$10.8 million Fall Research Competition

$11.5 million Graduate Student Support

$2.5 million Faculty Fellowships

$9.4 million UW2020: WARF Discovery Initiative

$5 million Grant Matches for Instrumentation, Facilities,Doctoral Training and Research Programs

$1.5 million Leadership, Personnel, Policy and Implementation Support

$100,000 Wisconsin Crop Improvement

$450,000 Biochemistry Innovation

$53.3 million Total Base Grant to the Office of the Vice Chancellor for Research and Graduate Education

$5.6 million Additional Grants, including Cluster Hire Initiative

$3 million Department Royalty Shares

$19 million Morgridge Institute for Research

$80.9 million Together, funding for all university andaffiliate organization categories for 2017-18

Annual grant amounts do not take into account the significant value of WARF’s in-kind support in covering patenting, licensing and other expenses.

Startups

Meet new partnersUnearth hidden gems

register at: mwdrugdevelopment.com

2,313

14510822

Sept. 30-Oct. 1, 2019 Omaha